AdvisorShares Psychedelics ETF (PSIL)
| Assets | $44.00M |
| Expense Ratio | 1.00% |
| PE Ratio | 40.05 |
| Forward PE | 17.42 |
| Shares Out | 2.15M |
| Dividend | $1.68 (8.20%) |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 326.97% |
| Volume | 8,842 |
| Open | 20.32 |
| Previous Close | 20.09 |
| Day's Range | 20.32 - 20.60 |
| 52-Week Low | 15.64 |
| 52-Week High | 27.02 |
| Beta | 1.01 |
| Holdings | 35 |
| Inception Date | Sep 15, 2021 |
About PSIL
Fund Home PageThe AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.
Top 10 Holdings
65.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Definium Therapeutics, Inc. | DFTX | 11.80% |
| COMPASS Pathways plc | CMPS | 11.60% |
| Helus Pharma Inc. | HELP | 8.58% |
| AbbVie Inc. | ABBV | 5.51% |
| Eli Lilly and Company | LLY | 5.44% |
| Neurocrine Biosciences, Inc. | NBIX | 4.98% |
| Johnson & Johnson | JNJ | 4.69% |
| Relmada Therapeutics, Inc. | RLMD | 4.63% |
| NRx Pharmaceuticals, Inc. | NRXP | 4.44% |
| Bright Minds Biosciences Inc. | DRUG | 4.31% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $1.6839 | Dec 29, 2025 |
| Sep 22, 2025 | $0.0201 | Sep 29, 2025 |
| Jun 23, 2025 | $0.01191 | Jun 27, 2025 |
| Mar 21, 2025 | $0.16343 | Mar 28, 2025 |
| Dec 23, 2024 | $0.0548 | Dec 30, 2024 |
| Sep 23, 2024 | $0.1087 | Sep 30, 2024 |
Performance
PSIL had a total return of 12.21% in the past year, including dividends. Since the fund's inception, the average annual return has been -24.66%.
News
Pacifica Silver Reports Strong Gold-Silver Intercepts at Claudia Project and Extends Justina Vein to 600 Metres in Strike Length
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Pacifica Silver Corp. (CSE: PSIL) (OTCQB: PAGFF) ("Pacifica Silver" or the "Company") is pleased to announce assay results from an addit...
AdvisorShares Applauds Executive Order Accelerating Access to Psychedelic Therapies
Portfolio manager of the AdvisorShares Psychedelics ETF (PSIL) calls executive action a pivotal moment for psychedelic medicine BETHESDA, Md., April 20, 2026 /PRNewswire/ -- AdvisorShares, a leading s...